We are live on ! Find out more
SRTAW

Strata Critical Medical Inc Warrants

Delisted

SRTAW was delisted on the 6th of May, 2026.

11 hedge funds and large institutions have $6.26M invested in Strata Critical Medical Inc Warrants in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

4% more capital invested

Capital invested by funds: $6.02M → $6.26M (+$248K)

0.18% more ownership

Funds ownership: 9.46%9.64% (+0.18%)

15% less funds holding

Funds holding: 1311 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
1
Closed
4
Calls
$714K
Puts
Net Calls
+$714K
Net Calls Change
-$44K
Name Holding Trade Value Shares
Change
Change in
Stake
LP
1
LMR Partners
United Kingdom
$3.44M +$100K +162,000 +19%
Goldman Sachs
2
Goldman Sachs
New York
$1.1M
Walleye Capital
3
Walleye Capital
New York
$850K +$40.4K +65,471 +4%
ICM
4
Ionic Capital Management
New York
$389K
Morgan Stanley
5
Morgan Stanley
New York
$336K
DCM
6
Difesa Capital Management
New York
$101K
SCM
7
Saba Capital Management
New York
$14.5K
HF
8
HRT Financial
New York
$14K -$6.94K -11,240 -28%
Two Sigma Investments
9
Two Sigma Investments
New York
$13.1K +$16.9K +27,300 New
AAS
10
Ameritas Advisory Services
Nebraska
$4.08K +$5.25K +8,500 New
SM
11
Skaana Management
New York
-$39.7K -79,406 Closed
CL
12
CSS LLC
Illinois
-$10.1K -20,165 Closed
OMC
13
Old Mission Capital
Illinois
-$5.26K -10,526 Closed
UBS Group
14
UBS Group
Switzerland
-$464 -927 Closed

SRTAW Hedge Fund Activity: Q1 2023 in Review

11 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q1 2023, worth a combined $6.26M — up 4.1% from $6.02M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SRTAW and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was LMR Partners, adding an estimated $100K. The largest seller was Skaana Management, exiting entirely with an estimated $39.7K sold.

  • 11 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q1 2023, down from 13 in Q4 2022.
  • Funds reported $6.26M of Strata Critical Medical Inc Warrants stock for Q1 2023, up 4.1% quarter-over-quarter.
  • 2 funds opened new Strata Critical Medical Inc Warrants positions in Q1 2023 and 4 closed out, a net change of -2 holders.
  • The largest Strata Critical Medical Inc Warrants buyer in Q1 2023 was LMR Partners, an estimated $100K added.
  • The largest Strata Critical Medical Inc Warrants seller in Q1 2023 was Skaana Management, an estimated $39.7K sold.

Based on aggregated 13F filings for Q1 2023.